Conclusion Detection of KRAS mutations, particularly the G12 C subtype, may be significant for patients with CRC and has possible therapeutic implications.
← all excerpts
<i>KRAS</i>, <i>NRAS</i> and <i>BRAF</i> Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients.
1
—
—